196 related articles for article (PubMed ID: 29748630)
1. Interaction between TSPO-a neuroimmune marker-and redox status in clinical high risk for psychosis: a PET-MRS study.
Hafizi S; Da Silva T; Meyer JH; Kiang M; Houle S; Remington G; Prce I; Wilson AA; Rusjan PM; Sailasuta N; Mizrahi R
Neuropsychopharmacology; 2018 Jul; 43(8):1700-1705. PubMed ID: 29748630
[TBL] [Abstract][Full Text] [Related]
2. GABA levels and TSPO expression in people at clinical high risk for psychosis and healthy volunteers: a PET-MRS study.
Da Silva T; Hafizi S; Rusjan PM; Houle S; Wilson AA; Prce I; Sailasuta N; Mizrahi R
J Psychiatry Neurosci; 2019 Mar; 44(2):111-119. PubMed ID: 30255837
[TBL] [Abstract][Full Text] [Related]
3. Imaging Microglial Activation in Individuals at Clinical High Risk for Psychosis: an In Vivo PET Study with [
Hafizi S; Da Silva T; Gerritsen C; Kiang M; Bagby RM; Prce I; Wilson AA; Houle S; Rusjan PM; Mizrahi R
Neuropsychopharmacology; 2017 Dec; 42(13):2474-2481. PubMed ID: 28604733
[TBL] [Abstract][Full Text] [Related]
4. TSPO expression and brain structure in the psychosis spectrum.
Hafizi S; Guma E; Koppel A; Da Silva T; Kiang M; Houle S; Wilson AA; Rusjan PM; Chakravarty MM; Mizrahi R
Brain Behav Immun; 2018 Nov; 74():79-85. PubMed ID: 29906515
[TBL] [Abstract][Full Text] [Related]
5. Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [
Hafizi S; Tseng HH; Rao N; Selvanathan T; Kenk M; Bazinet RP; Suridjan I; Wilson AA; Meyer JH; Remington G; Houle S; Rusjan PM; Mizrahi R
Am J Psychiatry; 2017 Feb; 174(2):118-124. PubMed ID: 27609240
[TBL] [Abstract][Full Text] [Related]
6. Neuroinflammation in healthy aging: a PET study using a novel Translocator Protein 18kDa (TSPO) radioligand, [(18)F]-FEPPA.
Suridjan I; Rusjan PM; Voineskos AN; Selvanathan T; Setiawan E; Strafella AP; Wilson AA; Meyer JH; Houle S; Mizrahi R
Neuroimage; 2014 Jan; 84():868-75. PubMed ID: 24064066
[TBL] [Abstract][Full Text] [Related]
7. Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA.
Kenk M; Selvanathan T; Rao N; Suridjan I; Rusjan P; Remington G; Meyer JH; Wilson AA; Houle S; Mizrahi R
Schizophr Bull; 2015 Jan; 41(1):85-93. PubMed ID: 25385788
[TBL] [Abstract][Full Text] [Related]
8. Preliminary data indicating a connection between stress-induced prefrontal dopamine release and hippocampal TSPO expression in the psychosis spectrum.
Schifani C; Hafizi S; Tseng HH; Gerritsen C; Kenk M; Wilson AA; Houle S; Rusjan PM; Mizrahi R
Schizophr Res; 2019 Nov; 213():80-86. PubMed ID: 30409695
[TBL] [Abstract][Full Text] [Related]
9. Microglia imaging in methamphetamine use disorder: a positron emission tomography study with the 18 kDa translocator protein radioligand [F-18]FEPPA.
Rathitharan G; Truong J; Tong J; McCluskey T; Meyer JH; Mizrahi R; Warsh J; Rusjan P; Kennedy JL; Houle S; Kish SJ; Boileau I
Addict Biol; 2021 Jan; 26(1):e12876. PubMed ID: 32017280
[TBL] [Abstract][Full Text] [Related]
10. Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant Data.
Plavén-Sigray P; Matheson GJ; Collste K; Ashok AH; Coughlin JM; Howes OD; Mizrahi R; Pomper MG; Rusjan P; Veronese M; Wang Y; Cervenka S
Biol Psychiatry; 2018 Sep; 84(6):433-442. PubMed ID: 29653835
[TBL] [Abstract][Full Text] [Related]
11. Quantitative imaging of neuroinflammation in human white matter: a positron emission tomography study with translocator protein 18 kDa radioligand, [18F]-FEPPA.
Suridjan I; Rusjan PM; Kenk M; Verhoeff NP; Voineskos AN; Rotenberg D; Wilson AA; Meyer JH; Houle S; Mizrahi R
Synapse; 2014 Nov; 68(11):536-47. PubMed ID: 25043159
[TBL] [Abstract][Full Text] [Related]
12. State-associated changes in longitudinal [
De Picker L; Ottoy J; Verhaeghe J; Deleye S; Wyffels L; Fransen E; Kosten L; Sabbe B; Coppens V; Timmers M; de Boer P; Van Nueten L; Op De Beeck K; Oberacher H; Vanhoenacker F; Ceyssens S; Stroobants S; Staelens S; Morrens M
Brain Behav Immun; 2019 Mar; 77():46-54. PubMed ID: 30503836
[TBL] [Abstract][Full Text] [Related]
13. Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [
Collste K; Plavén-Sigray P; Fatouros-Bergman H; Victorsson P; Schain M; Forsberg A; Amini N; Aeinehband S; ; Erhardt S; Halldin C; Flyckt L; Farde L; Cervenka S
Mol Psychiatry; 2017 Jun; 22(6):850-856. PubMed ID: 28194003
[TBL] [Abstract][Full Text] [Related]
14. In vivo imaging translocator protein (TSPO) in autism spectrum disorder.
Simpson D; Gharehgazlou A; Da Silva T; Labrie-Cleary C; Wilson AA; Meyer JH; Mizrahi R; Rusjan PM
Neuropsychopharmacology; 2022 Jun; 47(7):1421-1427. PubMed ID: 35383319
[TBL] [Abstract][Full Text] [Related]
15. Glutathione, the Major Redox Regulator, in the Prefrontal Cortex of Individuals at Clinical High Risk for Psychosis.
Da Silva T; Hafizi S; Andreazza AC; Kiang M; Bagby RM; Navas E; Laksono I; Truong P; Gerritsen C; Prce I; Sailasuta N; Mizrahi R
Int J Neuropsychopharmacol; 2018 Apr; 21(4):311-318. PubMed ID: 29618014
[TBL] [Abstract][Full Text] [Related]
16. Translocator protein (18kDa TSPO) binding, a marker of microglia, is reduced in major depression during cognitive-behavioral therapy.
Li H; Sagar AP; Kéri S
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():1-7. PubMed ID: 29269262
[TBL] [Abstract][Full Text] [Related]
17. The association of psychosocial risk factors for mental health with a brain marker altered by inflammation: A translocator protein (TSPO) PET imaging study.
Dahoun T; Calcia MA; Veronese M; Bloomfield P; Reis Marques T; Turkheimer F; Howes OD
Brain Behav Immun; 2019 Aug; 80():742-750. PubMed ID: 31112791
[TBL] [Abstract][Full Text] [Related]
18. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes.
Setiawan E; Wilson AA; Mizrahi R; Rusjan PM; Miler L; Rajkowska G; Suridjan I; Kennedy JL; Rekkas PV; Houle S; Meyer JH
JAMA Psychiatry; 2015 Mar; 72(3):268-75. PubMed ID: 25629589
[TBL] [Abstract][Full Text] [Related]
19. [
Vignal N; Cisternino S; Rizzo-Padoin N; San C; Hontonnou F; Gelé T; Declèves X; Sarda-Mantel L; Hosten B
Molecules; 2018 Jun; 23(6):. PubMed ID: 29875332
[TBL] [Abstract][Full Text] [Related]
20. Astroglial Connexin 43 Deficiency Protects against LPS-Induced Neuroinflammation: A TSPO Brain µPET Study with [
Vignal N; Boulay AC; San C; Cohen-Salmon M; Rizzo-Padoin N; Sarda-Mantel L; Declèves X; Cisternino S; Hosten B
Cells; 2020 Feb; 9(2):. PubMed ID: 32046185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
